Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
STTK

STTK - Shattuck Labs Inc Stock Price, Fair Value and News

6.18USD-0.66 (-9.65%)Market Closed

Market Summary

STTK
USD6.18-0.66
Market Closed
-9.65%

STTK Stock Price

View Fullscreen

STTK RSI Chart

STTK Valuation

Market Cap

293.7M

Price/Earnings (Trailing)

-3.45

Price/Sales (Trailing)

108.17

Price/Free Cashflow

-4.12

STTK Price/Sales (Trailing)

STTK Profitability

Return on Equity

-66.05%

Return on Assets

-58.14%

Free Cashflow Yield

-24.27%

STTK Fundamentals

STTK Revenue

Revenue (TTM)

2.7M

Rev. Growth (Yr)

1.9K%

Rev. Growth (Qtr)

56.16%

STTK Earnings

Earnings (TTM)

-85.1M

Earnings Growth (Yr)

10.71%

Earnings Growth (Qtr)

-4.62%

Breaking Down STTK Revenue

Last 7 days

-12.0%

Last 30 days

-24.3%

Last 90 days

-29.0%

Trailing 12 Months

122.3%

How does STTK drawdown profile look like?

STTK Financial Health

Current Ratio

9.15

STTK Investor Care

Shares Dilution (1Y)

11.97%

Diluted EPS (TTM)

-1.93

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20242.7M000
2023755.5K859.0K1.3M1.7M
2022020.2M10.4M652.0K
20219.2M07.9M30.0M
20209.9M9.9M9.9M9.9M
20190009.9M

Tracking the Latest Insider Buys and Sells of Shattuck Labs Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 04, 2024
schreiber taylor
acquired
10,888
3.57
3,050
chief executive officer
May 10, 2024
stout stephen
sold (taxes)
-20,152
10.42
-1,934
see remarks
Mar 28, 2024
redmile group, llc
sold
-
-
-4,425
-
Mar 06, 2024
stout stephen
acquired
39,380
3.54489
11,109
see remarks
Mar 06, 2024
stout stephen
sold
-168,522
10.53
-16,004
see remarks
Jan 30, 2024
stout stephen
sold (taxes)
-5,924
9.99
-593
see remarks
Jan 30, 2024
shukla abhinav a.
sold (taxes)
-22,877
9.99
-2,290
chief technical officer
Jan 30, 2024
pandite arundathy n.
sold (taxes)
-29,170
9.99
-2,920
chief medical officer
Jan 30, 2024
deyoung casi
sold (taxes)
-20,059
9.99
-2,008
chief business officer

1–10 of 50

Which funds bought or sold STTK recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 20, 2024
Virtu Financial LLC
new
-
113,000
113,000
0.01%
May 16, 2024
JANE STREET GROUP, LLC
added
1,150
3,109,770
3,321,680
-%
May 15, 2024
Squarepoint Ops LLC
new
-
521,577
521,577
-%
May 15, 2024
Brevan Howard Capital Management LP
new
-
367,407
367,407
-%
May 15, 2024
MILLENNIUM MANAGEMENT LLC
added
5,652
5,398,810
5,474,710
-%
May 15, 2024
Man Group plc
added
630
733,479
823,374
-%
May 15, 2024
MARSHALL WACE, LLP
new
-
692,806
692,806
-%
May 15, 2024
PRELUDE CAPITAL MANAGEMENT, LLC
sold off
-100
-377,890
-
-%
May 15, 2024
SYMMETRY PEAK MANAGEMENT LLC
sold off
-100
-10,695
-
-%
May 15, 2024
Laurion Capital Management LP
unchanged
-
1,196,480
5,909,680
0.05%

1–10 of 47

Are Funds Buying or Selling STTK?

Are funds buying STTK calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own STTK
No. of Funds

Unveiling Shattuck Labs Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 29, 2024
adage capital partners gp, l.l.c.
5.47%
2,577,705
SC 13G
Jan 02, 2024
prosight management, lp
5.9%
2,782,797
SC 13G
Dec 26, 2023
redmile group, llc
12.0%
5,664,892
SC 13D/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Dec 09, 2022
hornblower josiah
7.0%
2,977,627
SC 13D/A
Jun 09, 2022
blackrock inc.
4.97%
2,110,075
SC 13G
Feb 14, 2022
ecor1 capital, llc
0%
0
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 04, 2022
blackrock inc.
5.2%
2,209,819
SC 13G

Recent SEC filings of Shattuck Labs Inc

View All Filings
Date Filed Form Type Document
Jun 14, 2024
8-K
Current Report
Jun 11, 2024
8-K/A
Current Report
Jun 10, 2024
8-K
Current Report
Jun 05, 2024
4
Insider Trading
May 14, 2024
4
Insider Trading
May 02, 2024
8-K
Current Report
May 02, 2024
10-Q
Quarterly Report
Apr 23, 2024
DEFA14A
DEFA14A
Apr 23, 2024
DEF 14A
DEF 14A
Apr 23, 2024
ARS
ARS

Peers (Alternatives to Shattuck Labs Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
53.7B
6.8B
8.51% 7.74%
-8.99
7.84
-64.45% -224.75%
22.5B
216.3K
-0.77% 465779.94%
-2.5K
104.0K
- -8.13%
20.3B
2.0B
8.81% -20.73%
-61.09
10.13
75.20% 68.82%
15.9B
2.5B
3.83% -12.90%
77.15
6.41
13.74% 186.89%
13.9B
3.8B
8.85% -0.77%
18.71
3.7
8.58% 129.81%
MID-CAP
5.2B
107.9M
-7.07% 79.45%
-9.53
48.09
54.84% -28.31%
5.1B
524.1M
0.17% -53.14%
-12.21
9.72
394.93% 39.61%
3.5B
251.0M
-2.92% -12.90%
-11.81
13.95
73.58% -86.73%
3.2B
240.7M
3.27% -27.64%
-6.79
12.77
-1.03% -213.92%
2.5B
813.8M
-1.46% -38.91%
-1.4K
3.03
56.43% 98.83%
2.0B
996.6M
11.55% 78.54%
-5.07
2.03
-26.66% 65.49%
SMALL-CAP
1.8B
411.3M
-9.60% 21.75%
27.32
4.32
60.38% -34.49%
534.3M
881.7K
13.28% 545.16%
-15.83
481.06
-77.61% 33.36%
235.5M
4.2M
-30.45% 48.53%
-1.89
56.62
-66.30% 48.24%
22.1M
2.1M
36.17% 264.31%
-0.95
7.61
-13.45% 69.54%

Shattuck Labs Inc News

Latest updates
Simply Wall St18 hours ago
TradingView4 months ago

Shattuck Labs Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22021Q42021Q32021Q12020Q42020Q32020Q22020Q12019Q42019Q3
Revenue56.2%1,11571468620057.003902127751,3371,9002,2701,3422,4353,1812,9762,3801,784
Operating Expenses7.6%21,15919,66529,28422,94721,71826,66625,44127,70820,83219,48014,69313,35314,2749,5019,737-9,311
  S&GA Expenses10.3%4,8954,4385,0734,7425,0514,7796,5794,7454,6254,3434,3563,5662,4701,7461,600-1,366
  R&D Expenses6.8%16,26415,22724,21118,20516,66721,88718,86222,96316,20715,13710,3379,78711,8047,7558,137-7,945
Net Income-4.6%-18,504-17,687-27,541-21,346-20,724-25,411-24,635-27,3717,847-17,410-11,813-12,012-11,829-6,208-6,554-7,369-7,279
Net Income Margin40.5%-31.34*-52.68*-71.28*-107.24*-129.90*-156.36*-6.58*-3.04*-1.50*-8.16*-4.54*------
Free Cashflow16.9%-16,161-19,436-16,751-18,912-26,536-24,534-28,814-23,999-20,707-13,956-13,706------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32019Q4
Assets-8.3%14616013015517820522325127029931132433734914545.00
  Current Assets-8.5%13114311313615818520222925528830231633134614242.00
    Cash Equivalents-39.5%76.0012641.0072.0066.0047.0040.0038.0051.0092.0085.0086.0085.001581297.00
  Net PPE-7.1%13.0014.0015.0016.0017.0018.0018.0019.0012.0010.009.008.005.003.003.002.00
Liabilities17.9%18.0015.0018.0017.0020.0029.0024.0029.0022.0027.0049.0047.0038.0039.0037.0030.00
  Current Liabilities25.1%14.0011.0014.0013.0016.0025.0019.0024.0017.0025.0020.0015.0018.0017.0016.0020.00
Shareholder's Equity-11.0%129145113138158176199223249272261277299310--
  Retained Earnings-6.0%-324-306-288-261-239-219-193-168-141-117-124-107-83.91-72.09-60.08-35.49
  Additional Paid-In Capital0.6%4544514014003983963943933913893883863833822.001.00
Shares Outstanding0.5%48.0047.0042.0042.0042.0042.0042.0042.0042.0042.0042.0042.0042.00---
Float----86.00---111---690--554-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q3
Cashflow From Operations16.8%-16,161-19,419-16,732-18,616-26,461-23,841-28,064-16,316-26,277-18,717-12,992-14,339-11,068-14,043-11,3482,185-10,453--
  Share Based Compensation50.9%2,4751,6401,7641,8521,6831,6931,7231,5331,5131,2161,3441,7271,180637312143174--
Cashflow From Investing-159.6%-33,27655,851-14,55024,43345,12531,46229,9253,433-15,38225,60111,24014,843-62,127-171,4889,9878,4816,698--
Cashflow From Financing-100.4%-18448,56221.0033.00--27.0010.001342903521,25631.00214,829-1,08382,68734,433--
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

STTK Income Statement

2024-03-31
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Collaboration revenue$ 1,115$ 57
Revenue from Contract with Customer, Product and Service [Extensible List]LicenseLicense
Operating expenses:  
Research and development$ 16,264$ 16,667
General and administrative4,8955,051
Expense from operations21,15921,718
Loss from operations(20,044)(21,661)
Other income1,540937
Net loss(18,504)(20,724)
Unrealized (loss) gain on investments(18)538
Comprehensive loss$ (18,522)$ (20,186)
Net loss per share – basic (in dollars per share)$ (0.37)$ (0.49)
Net loss per share – diluted (in dollars per share)$ (0.37)$ (0.49)
Weighted-average shares outstanding – basic (in shares)50,566,39442,439,204
Weighted-average shares outstanding – diluted (in shares)50,566,39442,439,204

STTK Balance Sheet

2024-03-31
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 76,005$ 125,626
Investments38,6284,999
Prepaid expenses and other current assets16,44312,595
Total current assets131,076143,220
Property and equipment, net12,83013,804
Other assets2,4292,540
Total assets146,335159,564
Current liabilities:  
Accounts payable2,1541,587
Accrued expenses and other current liabilities7,5699,523
Contract with Customer, Liability, Current4,606343
Total current liabilities14,32911,453
Non-current operating lease liabilities3,1933,406
Total liabilities17,52214,859
Commitments and contingencies (Note 5)
Stockholders’ equity:  
Common stock, $0.0001 par value: 300,000,000 shares authorized; 47,519,219 shares issued and outstanding at March 31, 2024 and 47,260,108 shares issued and outstanding at December 31, 202355
Additional paid-in capital453,636451,006
Accumulated other comprehensive (loss) income(14)4
Accumulated deficit(324,814)(306,310)
Total stockholders’ equity128,813144,705
Total liabilities and stockholders’ equity$ 146,335$ 159,564
STTK
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.
 CEO
 WEBSITEshattucklabs.com
 INDUSTRYBiotechnology
 EMPLOYEES105

Shattuck Labs Inc Frequently Asked Questions


What is the ticker symbol for Shattuck Labs Inc? What does STTK stand for in stocks?

STTK is the stock ticker symbol of Shattuck Labs Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Shattuck Labs Inc (STTK)?

As of Fri Jun 14 2024, market cap of Shattuck Labs Inc is 293.67 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of STTK stock?

You can check STTK's fair value in chart for subscribers.

What is the fair value of STTK stock?

You can check STTK's fair value in chart for subscribers. The fair value of Shattuck Labs Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Shattuck Labs Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for STTK so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Shattuck Labs Inc a good stock to buy?

The fair value guage provides a quick view whether STTK is over valued or under valued. Whether Shattuck Labs Inc is cheap or expensive depends on the assumptions which impact Shattuck Labs Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STTK.

What is Shattuck Labs Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jun 14 2024, STTK's PE ratio (Price to Earnings) is -3.45 and Price to Sales (PS) ratio is 108.17. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STTK PE ratio will change depending on the future growth rate expectations of investors.